drugset / Trial / NCT00827515

Relative Bioavailability and Food Effect Study

NCT00827515

Phase 1 Withdrawn Pfizer
RandomizedCrossoverOpen-labelBasic science

Summary

Initial studies have used a powder in capsule formulation of PH797804. In future studies an immediate release tablet will be used. The purpose of this study is to compare blood levels of PH797804 following an oral dose of the powder in capsule formulation and the tablet formulation. In addition the effect of food blood levels of PH797804 will be investigated

Timeline

Start
2009-02
Primary completion
2009-04
Completion
2009-05

Drugs

EvaluationDrugModalityDoseRoute
Subject PH-797804 Small molecule 5 mg Oral

Indications

No indication recorded.